Sleep induction in chronic insomnia
Schneider-Helmert and colleagues published a series of small clinical reports in the 1980s using synthetic DSIP IV in chronic insomniacs, with reports of longer sleep duration, fewer interruptions, and slightly more REM sleep. The literature is small (N typically < 30 per study), the molecule is not approved as a sleep agent anywhere, and modern trials with proper polysomnography control have not been replicated.
3 human studies · 8 animal studies
Key findings & citations
- Schneider-Helmert 1981: longer sleep duration and quality with synthetic DSIP IV in chronic insomniacs.
- 1987 case: delayed sleep phase advanced by 5 hours with DSIP, withdrawing benzodiazepine.
- All published trials are small, dated (1980s), and lack modern polysomnography rigor.
- Not approved as a sleep agent in any major market.
Our take
Old literature, small trials, never approved. Modern sleep medicine has moved on; community use is largely nostalgic.